Podcasts about Acute respiratory distress syndrome

Before 2020 Laura worked night and day to achieve her dream of being on Saturday Night Live. Then she got Covid and months later woke up from a coma completely paralyzed and unable to communicate. Today she lives with Acute Respiratory Distress Syndrome caused by scarred lungs and a whole new outlook. With new found grit and purpose Laura shares her humor on TikTok and hosts a podcast called "Iconically Ill."    2 Lives “The second begins the moment we realize we have only one.” 2 Lives is created by Laurel Morales. Valerie Shively is the assistant producer. Christian Arnder is our illustrator and website designer. Music from Blue Dot Sessions. Subscribe to Laurel's Substack here. Support 2 Lives at https://ko-fi.com/2livespodcast You can learn more about how to support the show here. Or order merch here. Drop us a note on Facebook, Instagram, or Twitter.   Find out more about Laura Lyons and read the episode transcript at our website.  

This episode originally aired on January 17th, 2024. Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, "A New Global Definition of Acute Respiratory Distress Syndrome."

Send us a textEs geht mal wieder um Intensivmedizin, ganz konkret um den Einsatz von Sevofluran zur inhalativen Sedierung im ARDS:Jabaudon M, Quenot J, Badie J, et al. Inhaled Sedation in Acute Respiratory Distress Syndrome: The SESAR Randomized Clinical Trial. JAMA. Published online March 18, 2025. doi:10.1001/jama.2025.3169Im Studio mit dabei: Dr. Chiara Heim, wissenschaftliche Mitarbeiterin der Klinik für Anästhesiologie am UKHD

Send us a Text Message (please include your email so we can respond!)Episode 62! We talk briefly about two of the analyses that dropped with the ISICEM conference and then talk in depth about SESAR or "Inhaled Sedation in Acute Respiratory Distress Syndrome" by Jabudon et al in JAMA 2025. Then was answer a question on sleep in the ICU. Eddie did misspeak when he said one of the dexmedetomidine articles was in Lancet Respiratory medicine, rather, it was published in eClinical Medicine part of the Lancet network.SESAR (JAMA): https://jamanetwork.com/journals/jama/fullarticle/2831857SESAR (pubmed): https://pubmed.ncbi.nlm.nih.gov/40098564/OVISS (pubmed): https://pubmed.ncbi.nlm.nih.gov/40098600/Nocturnal dexmedetomidine (pubmed): https://pubmed.ncbi.nlm.nih.gov/29498534/Nocturnal dexmedetomidine cardiac surgery (pubmed): https://pubmed.ncbi.nlm.nih.gov/36590787/If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!

ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS. Related Content: Sevoflurane Sedation in Acute Respiratory Distress Syndrome Inhaled Sedation in Acute Respiratory Distress Syndrome

In this episode, we review the high-yield topic of⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠Acute Respiratory Distress Syndrome (ARDS)⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Respiratory section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

Send us a textProf. Dr. Niels Riedemann, MD, Ph.D. is Chief Executive Officer and Founder of InflaRx ( https://www.inflarx.de/Home/About-Inflarx/Team~Niels-C.-Riedemann~.html ), a biopharmaceutical company focused on applying its proprietary anti-C5a and C5aR inhibitors to the treatment of life-threatening or debilitating inflammatory diseases with high unmet medical need. Prof. Dr. Riedemann has over 15 years of experience in the biotech industry and drug development, as well as over 20 years of experience in complement immunology research. He founded InflaRx in 2007 and has served as Chief Executive Officer since inception of the company. He has been instrumental in and led numerous private and public financing rounds of the company and has been the responsible lead for its Nasdaq IPO in 2017. He is named inventor on several internationally granted core patents of InflaRx. As physician, Prof. Dr. Riedemann was appointed Vice Director (“Leitender Oberarzt”) of Intensive Care Medicine, and led a 50-bed University ICU unit for over 6 years at Friedrich Schiller University, Jena, Germany until 2015. Before that, he received his board certification as General Surgeon upon completion of his surgical fellowship at MHH (Hannover Medical School, Germany) in 2007 where he also received his habilitation (equivalent to Ph.D.) and where he still holds an Adjunct Professorship (APL Professor). He spent three years as postdoctoral research fellow at the University of Michigan, USA until 2003. He received his medical training at Albert Ludwig University (ALU), Freiburg, Germany, and Stanford University, USA and graduated as Dr. med. (equivalent to M.D.) from ALU in 1998. Prof. Dr. Riedemann's research has been awarded with several national and international awards. He has received extensive extra-mural funding and published over 60 peer reviewed scientific publications in highly ranked journals. He has served as a member on a Board of Directors and a Scientific Advisory Board of two large scientific governmental funded programs. He currently serves as Co-Chair of the Health Politics working group of Bio-Deutschland and he serves as member of the board of trustees for the German Sepsis Foundation.#NielsRiedemann #InflaRx #Inflammation #ComplementComponent5a  #Sepsis #AcuteRespiratoryDistressSyndrome #Covid #ARDS #GOHIBIC #Vilobelimab #PyodermaGangrenosum #ChronicSpontaneousUrticaria #HidradenitisSuppurativa #Preparedness #BARDA #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this episode of the JIM podcast, we meet with two of the co-first authors in the recent review article, “Acute respiratory distress syndrome: A review of ARDS across the life course”. Dr.  Caleb Cave is from the Department of Pediatrics -Division of Neonatology and Dr. Danielle Samano is from the Department of Internal Medicine- Pulmonary Critical Care, Sleep Medicine Division.  Both are at the University of Nebraska Medical Center are in the 2nd year of their respective fellowship programs. Here, we take a deep dive into acute respiratory distress syndrome (ARDS): common causes, complications, and management strategies in s structured compare and contrast format across the lifespan from neonates to adults.

In this World Shared Practice Forum podcast, Dr. Mark Peters discusses the Oxy-PICU trial, published in The Lancet in January 2024, which compared conservative to liberal oxygenation targets in critically ill children. The study highlighted the importance of pragmatic trial design and the need for larger trials to confirm these findings. LEARNING OBJECTIVES -Discuss the background driving the investigation of oxygenation in critically ill children -Summarize the study design of the Oxy-PICU Trial -Present the outcomes and challenges of the Oxy-PICU Trial -Identify the key characteristics of pragmatic trial design and the implication of pragmatic trial results AUTHORS Mark Peters, MBChB, MRCP, FFICM, FRCPCH, PhD Professor of Paediatric Intensive Care NIHR Senior Investigator UCL Great Ormond St Institute of Child Health Hon. Consultant Paediatric Intensivist Paediatric Intensive Care Unit and Children's Acute Transport Service Great Ormond St Hospital Jeffrey Burns, MD, MPH Emeritus Chief Division of Critical Care Medicine Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Professor of Anesthesia Harvard Medical School DATE Initial publication date: November 26, 2024. ARTICLES REFERENCED AND ADDITIONAL RESOURCES Peters MJ, Gould DW, Ray S, et al. Conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU): a UK multicentre, open, parallel-group, randomised clinical trial [published correction appears in Lancet. 2024 Jan 27;403(10424):354. doi: 10.1016/S0140-6736(24)00100-4]. Lancet. 2024;403(10424):355-364. https://pubmed.ncbi.nlm.nih.gov/38048787/ Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome [published correction appears in Am J Respir Crit Care Med. 2017 Jun 1;195(11):1540. doi: 10.1164/rccm.19511erratum]. Am J Respir Crit Care Med. 2017;195(9):1253-1263. https://pubmed.ncbi.nlm.nih.gov/28459336/ Peters MJ, Ramnarayan P. Randomized Trials to Reduce Clinical Uncertainty: Gold Standard or Fool's Gold? Pediatr Crit Care Med. 2024;25(8):775-777. https://pubmed.ncbi.nlm.nih.gov/39101806/ Darnell R, Brown A, Laing E, et al. Protocol for a Randomized Controlled Trial to Evaluate a Permissive Blood Pressure Target Versus Usual Care in Critically Ill Children with Hypotension (PRESSURE). Pediatr Crit Care Med. 2024;25(7):629-637. https://pubmed.ncbi.nlm.nih.gov/38629915/ Taccone FS, Rynkowski Bittencourt C, Møller K, et al. Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury: The TRAIN Randomized Clinical Trial. JAMA.Published online October 09, 2024. https://pubmed.ncbi.nlm.nih.gov/39382241/ Jones GAL, Eaton S, Orford M, et al. Randomization to a Liberal Versus Conservative Oxygenation Target: Redox Responses in Critically Ill Children. Pediatr Crit Care Med. 2023;24(3):e137-e146. https://pubmed.ncbi.nlm.nih.gov/36728001/ UK-ROX: https://www.icnarc.org/research-studies/uk-rox/ MegaROX: https://www.anzics.org/current-active-endorsed-research/mega-rox/ ICU-ROX: https://www.thebottomline.org.uk/summaries/icm/icu-rox/ TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/rq7kgwqkh4hk4nk67584pfj/202411_-_WSP_-_Less_is_more_Oxygenation_Targets_in_Critically_Ill_Children_-_Transcript?position=2 CITATION Peters MJ, Burns JP. Less is More: Oxygenation Targets in Critically Ill Children. 11/2024. OPENPediatrics. https://soundcloud.com/openpediatrics/less-is-more-oxygenation-targets-in-critically-ill-children-by-m-peters-openpediatrics.

On this week's episode, Cyrus & Nick tackle one of their biggest challenges yet: Acute Respiratory Distress Syndrome, more commonly known as ARDS.***WARNING*** this is no shorty! We cover all things ARDS from pathophysiology, diagnosis, treatments and things NOT to do. Dare we say, this is the definitive FOAM-ARDS experience for anyone and everyone who cares for people suffering from ARDS. Give it a listen and as always, send us your feedback!! Hosted on Acast. See acast.com/privacy for more information.

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Acute Respiratory Distress Syndrome (ARDS) ⁠⁠⁠⁠⁠⁠⁠⁠from the Pulmonary section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠ Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

FREE! 8 Steps to Becoming a CRNA: https://www.cspaedu.com/3m9jgffpJoin us for this enlightening episode of the CSPA Podcast as Dr. Jeremy Heiner, an esteemed educator with over 16 years of experience, dives deep into the complexities of Acute Respiratory Distress Syndrome (ARDS). Unpacking the evolution, pathophysiology, and modern treatment approaches of ARDS, today's special guest episode offers invaluable insights for ICU nurses and nurse anesthesia providers.Whether you're a seasoned practitioner or a nursing student eager to expand your critical care knowledge, this episode is packed with essential information that will enhance your understanding and skills in managing ARDS. Tune in for a masterclass in respiratory care and gain practical knowledge that could be crucial in your next shift in the ICU.Thousands of nurses have gained CRNA school acceptance with CRNA School Prep Academy. Join today for access to all of the tools proven to accelerate your CRNA success! Click here:https://cspaedu.com/joinGet CRNA School insights sent straight to your inbox! Join the CSPA email list: https://www.cspaedu.com/podcast-email Join the Free Facebook Community here! https://www.facebook.com/groups/crnaschoolprepacademyfreeBook a mock interview, resume or personal statement critique, transcript review and more: www.teachrn.comDr. Heiner has an extensive background in clinical anesthesia and is the co-author of several textbooks including Emergency Management in Anesthesia and Critical Care (EMAC), Critical Events in Anesthesia, & Nurse Anesthesia, the main textbook used by a majority of Nurse Anesthesia Programs. Learn More about The Nurse Anesthesia: https://thenurseanesthesia.com/

We have had a number of episodes on Acute Respiratory Distress Syndrome or ARDS. These episodes have ranged from how to titrate PEEP, subphenotypes in ARDS, and the future of ARDS research. Today, we are talking about how we all … Continue reading →

In this episode, Dr. Zanotti is joined by Dr. Stephen Pastores to discuss the 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia, published by the Society of Critical Care Medicine. Dr. Pastores is Program Director for Critical Care Medicine and Vice-Chair of Education for the Department of Anesthesiology and Critical Care Medicine at Memorial Sloan Kettering Cancer Center. In addition, Dr. Pastores is a professor of anesthesiology and medicine at Weill Cornell Medical College in New York, NY. Additional resources: 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Medicine 2024: https://journals.lww.com/ccmjournal/pages/articleviewer.aspx?year=9900&issue=00000&article=00275&type=Fulltext Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. ADRENAL Trial. N Engl J Med 2018. https://www.nejm.org/doi/full/10.1056/NEJMoa1705835 Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. APROCCHSS Clinical Trial. N Engl J of Med 2018: https://www.nejm.org/doi/full/10.1056/NEJMoa1705716 Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomized controlled trial. The Lancet 2020: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30417-5/abstract Hydrocortisone in Severe Community-Acquired Pneumonia. CAPE-COD Trial. N Eng J Med 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215145 Books mentioned in this episode: Elon Musk. By Walter Isaacson: https://bit.ly/3PVXWsG The Autumn Ghost: How the Battle Against a Polio Epidemic Revolutionized Modern Medical Care. By Hannah Wunsch: https://bit.ly/4avevns

We review Acute Respiratory Distress Syndrome Hosts: Sadakat Chowdhury, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/ARDS.mp3 Download Leave a Comment Tags: Critical Care, Pulmonary Show Notes Definition of ARDS: Non-cardiogenic pulmonary edema characterized by acute respiratory failure. Berlin criteria for diagnosis include acute onset within 7 days, bilateral pulmonary infiltrates on imaging, not fully explained by cardiac failure or fluid overload, and impaired oxygenation with PaO2/FiO2 ratio 5 cm H2O. Severity based on oxygenation (Berlin criteria): Mild: PaO2/FiO2 200-300 mmHg Moderate: PaO2/FiO2 100-200 mmHg Severe: PaO2/FiO2

https://www.cursotdc.com.br/antibiotico/lead/

In today's episode, we are exploring a multitude of respiratory diseases, including Obstructive Lung Disease, Restrictive Lung Disease, Upper Respiratory Infections, Acute Respiratory Distress Syndrome, Pulmonary Embolisms, Mediastinal masses, Bronchospasm, & Tension Hemothorax and how they affect our anesthetic care. We're examining the difference between obstructive and restrictive lung disease and how we should manage our patients accordingly. We'll talk about some of the various reasons that procedures should be rescheduled and the optimal timeframe for such rescheduling. Support the showTo access all of our content, download the CORE Anesthesia App available here on the App Store and here on Google Play. Want to connect? Check out our instagram or email us at info@coreanesthesia.com

In this World Shared Practice Forum Podcast, Dr. Martin Kneyber discusses the implementation of the PALICC-2 guidelines in bedside monitoring and management of pediatric acute respiratory distress syndrome (PARDS). He shares insights on how the concepts of positive end-expiratory pressure (PEEP), driving pressure, patient self-inflicted lung injury (P-SILI), and the use of non-invasive ventilation are translated to the bedside management of PARDS. LEARNING OBJECTIVES - Explain the concept of driving pressure and its significance in the management of pediatric acute lung injury - Identify the potential benefits and drawbacks of neuromuscular blockade in pediatric acute lung injury patients - Describe the concept of non-invasive ventilation in the management of acute respiratory failure in pediatric patients, including its potential benefits, limitations, and challenges in implementation AUTHORS Martin Kneyber MD, PhD, FCCM Chief of the Division of Paediatric Critical Care Medicine Beatrix Children's Hospital University Medical Center Groningen, Groningen, the Netherlands Jeffrey Burns MD, MPH Chief and Shapiro Chair, Division of Critical Care Medicine; Executive Chair, International Health Services Senior Associate in Critical Care Medicine; Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Professor of Anesthesia Harvard Medical School DATES Initial Publication Date: February 26, 2024. ARTICLES REFERENCED 00:58 https://pubmed.ncbi.nlm.nih.gov/36661420/ Emeriaud G, López-Fernández YM, Iyer NP, et al. Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2). Pediatr Crit Care Med. 2023;24(2):143-168. 01:46 https://pubmed.ncbi.nlm.nih.gov/29373802/ Khemani RG, Parvathaneni K, Yehya N, Bhalla AK, Thomas NJ, Newth CJL. Positive End-Expiratory Pressure Lower Than the ARDS Network Protocol Is Associated with Higher Pediatric Acute Respiratory Distress Syndrome Mortality. Am J Respir Crit Care Med. 2018;198(1):77-89. 02:53 https://pubmed.ncbi.nlm.nih.gov/30361119/ Khemani RG, Smith L, Lopez-Fernandez YM, et al. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study [published correction appears in Lancet Respir Med. 2018 Nov 13;:] [published correction appears in Lancet Respir Med. 2019 Mar;7(3):e12]. Lancet Respir Med. 2019;7(2):115-128. 07:45 https://pubmed.ncbi.nlm.nih.gov/25693014/ Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755. 07:49 https://pubmed.ncbi.nlm.nih.gov/36661438/ Yehya N, Smith L, Thomas NJ, et al. Definition, Incidence, and Epidemiology of Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2023;24(12 Suppl 2):S87-S98. 18:09 https://pubmed.ncbi.nlm.nih.gov/20843245/ Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116. 18:27 https://pubmed.ncbi.nlm.nih.gov/27779896/ Huang DT, Angus DC, Moss M, et al. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome. Ann Am Thorac Soc. 2017;14(1):124-133. 19:26 https://pubmed.ncbi.nlm.nih.gov/27748627/ Doorduin J, Nollet JL, Roesthuis LH, et al. Partial Neuromuscular Blockade during Partial Ventilatory Support in Sedated Patients with High Tidal Volumes. Am J Respir Crit Care Med. 2017;195(8):1033-1042. Kneyber MCJ, O'Hara JE, Burns JP. Bedside Implementation of the PALICC-2 Guidelines. 2/2024. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/bedside-implementation-of-the-palicc-2-guidelines-by-m-kneyber-openpediatrics.

This episode delves into the 2024 update on corticosteroid guidelines for critically ill patients with sepsis, ARDS, and community-acquired pneumonia. We break down the recommendations, evidence, and clinical implications of this crucial guidance for healthcare providers. The Vasopressor & Inotrope Handbook: ⁠⁠⁠⁠Amazon Affiliate Link⁠⁠⁠⁠ (I will earn an extra small commission) and ⁠⁠⁠⁠Signed/Personalized Copies⁠⁠⁠⁠. Citation: Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena RS, Carcillo JA, Correa R, Drover K, Esper AM, Gershengorn HB, Hammond NE, Jayaprakash N, Menon K, Nazer L, Pitre T, Qasim ZA, Russell JA, Santos AP, Sarwal A, Spencer-Segal J, Tilouche N, Annane D, Pastores SM. Executive Summary: Guidelines on Use of Corticosteroids in Critically Ill Patients With Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia Focused Update 2024. Crit Care Med. 2024 Jan 19. doi: 10.1097/CCM.0000000000006171. Epub ahead of print. PMID: 38240490. --- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support

Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, "A New Global Definition of Acute Respiratory Distress Syndrome."

Moderator: James P. Rathmell, M.D. Participants: Mattia Busana, M.D. and Marcos F. Vidal Melo, M.D., Ph.D. Articles Discussed: The Causes of Hypoxemia of COVID-19 ARDS: A Combined MIGET and Dual-Energy CT Study Structure–Function Relationships Determining Hypoxemia in COVID-19 Acute Respiratory Distress Syndrome

Are adults with ADHD at increased risk for dementia? Find out about this and more in today's PV Roundup podcast.

Paula Blonski, President ARDS Alliance Rick Bressler, ARDS Survivor Today we had an interesting conversation with Paula Blonski, President-ARDS Alliance and Rick Bressler a patient who had Covid double lung pneumonia, Covid induced ARDS, but he ultimately needed a double lung transplant to survive.  Acute respiratory distress syndrome (ARDS) is an acute, diffuse, inflammatory form of lung injury and life-threatening condition in seriously ill patients, characterized by poor oxygenation, pulmonary infiltration, and acute onset. ARDS Alliance Website https://ardsalliance.org/

JAMA Associate Editor David L. Simel, MD, MHS, discusses the latest European Society of Intensive Care Medicine (ESICM) Guidelines on Acute Respiratory Distress Syndrome, which were released in June 2023, with Derek C. Angus, MD, MPH, University of Pittsburgh. Related Content: Caring for Patients With Acute Respiratory Distress Syndrome

In this episode, we will discuss prone position ventilation in adult respiratory distress syndrome (ARDS). Despite clinical trials demonstrating a benefit on mortality, the adoption of prone position ventilation has been challenging. We will discuss the impact the COVID-19 pandemic had on the use of prone position ventilation and lessons learned that can help increase the proper use of this treatment modality moving forward. Our guest is Dr. Chad Hochberg, a member of the Division of Pulmonary and Critical Care Medicine, Department of Medicine, at John Hopkins University Medical School in Baltimore, Maryland. Additional Resources Factors Influencing the Implementation of Prone Positioning during the COVID-19 Pandemic. Hochberg C, et al. Ann Am Thorac Soc, 2023; https://pubmed.ncbi.nlm.nih.gov/35947776/ Declining Use of Prone Positioning After High Initial Uptake in COVID-19 Adult Respiratory Distress Syndrome. Hochberg C, et al. Crit Care Med 2023: https://pubmed.ncbi.nlm.nih.gov/37294144/ ESICM Guidelines on ARDS 2023. Intensive Care Medicine 2023: https://link.springer.com/article/10.1007/s00134-023-07050-7 ATS/ESICM/SCCM Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome: https://www.atsjournals.org/doi/10.1164/rccm.201703-0548S Prone Position for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Munshi L, et al. Ann Am Thorac Soc 2017: https://pubmed.ncbi.nlm.nih.gov/29068269/ Prone Positioning in Severe Acute Respiratory Distress Syndrome. Guerin C. Et al. PROSEVA Trial. New Eng J Med 2013: https://www.nejm.org/doi/full/10.1056/nejmoa1214103 Books Mentioned in this Episodes The Omnivore's Dilemma: A Natural History of Four Meals, By Michael Pollan: https://bit.ly/42FpndS

Looking for more information on this topic? Check out the Acute Respiratory Distress Syndrome brick. If you enjoyed this episode, we'd love for you to leave a review on Apple Podcasts.  It helps with our visibility, and the more med students (or future med students) listen to the podcast, the more we can provide to the future physicians of the world. Follow USMLE-Rx at: Facebook: www.facebook.com/usmlerx Blog: www.firstaidteam.com Twitter: https://twitter.com/firstaidteam Instagram: https://www.instagram.com/firstaidteam/ YouTube: www.youtube.com/USMLERX Learn how you can access over 150 of our bricks for FREE: https://usmlerx.wpengine.com/free-bricks/ from our Musculoskeletal, Skin, and Connective Tissue collection, which is available for free. Learn more about Rx Bricks by signing up for a free USMLE-Rx account: www.usmle-rx.com You will get 5 days of full access to our Rx360+ program, including nearly 800 Rx Bricks.  After the 5-day period, you will still be able to access over 150 free bricks, including the entire collections for General Microbiology and Cellular and Molecular Biology.

Sarah is welcoming back Christian Guzman APRN on the show for a two-part series on acute respiratory distress syndrome, otherwise known as ARDS. Don't know how to properly diagnose ARDS, or treat it without further damaging the lungs? This episode will answer your questions!Christian shares the case of a patient who presented with abnormal symptoms for his age, and how they reached an ARDS diagnosis. ARDS is a secondary diagnosis, so you'll also hear how to differentiate between ARDS and other conditions like pneumonia, aspiration, congestive heart failure, viral infections, etc.In this episode, Christian gives a history of ARDS, how our treatment methods have changed, and why lung protective ventilation is essential for care. He also details the 3 types of trauma that can occur with ventilation, including atelectotrauma, barotrauma and volutrauma, plus one newer trauma that's showing up in the literature.For a breakdown of the history, pathology, and treatment for ARDS, listen to this conversation!Topics discussed in this episode:Christian's career in critical careHis patient's unusual presentation in the ERWhat the patient's tests showed and what was concerningThe cause of the patient's pleural effusionDiagnostic criteria for ARDSThe progression of ARDSHow we treat ARDSTypes of ventilation traumaHow to prevent harm and promote resting of the lungsIf you would like to check out Sarah's 1hr, 1 CE course, go to: http://www.rapidresponseandrescue.comTo get the FREE Rapid Response RN Assessment Guide and the coupon code for $10 off the cost of the course, message Sarah on Instagram @TheRapidResponseRN and type the word PODCAST!This episode was produced by Podcast Boutique http://www.podcastboutique.comMentioned in this episode:AND If you are planning to sit for your CCRN and would like to take the Critical Care Academy CCRN prep course you can visit https://www.ccrnacademy.com and use coupon code RAPID10 to get 10% off the cost of the course!

In this podcast, I've spoken about the complexity of ARDS, risk factors, pathophysiology and treatment strategies. You can check out the references - 1. Gragossian A, Siuba MT. Acute Respiratory Distress Syndrome. Emerg Med Clin North Am. 2022 Aug;40(3):459-472. doi: 10.1016/j.emc.2022.05.002. Epub 2022 May 10. PMID: 35953211; PMCID: PMC9085508. 2. Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021 Aug 14;398(10300):622-637. doi: 10.1016/S0140-6736(21)00439-6. Epub 2021 Jul 1. PMID: 34217425; PMCID: PMC8248927. 3. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75. doi: 10.1056/NEJMoa062200. Epub 2006 May 21. PMID: 16714767. 4. Yadav H, Thompson BT, Gajic O. Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease? Am J Respir Crit Care Med. 2017 Mar 15;195(6):725-736. doi: 10.1164/rccm.201609-1767CI. PMID: 28040987.

Anthony Repay is currently serving as Laboratory Director of Method Testing Laboratories in Tampa, FL. Anthony started his career as the head food and environmental microbiologist at a Chicago-based testing laboratory before joining the cannabis science community. Since joining cannabis, Anthony has tried to innovate and push the cannabis microbiology community by publishing peer-reviewed papers, speaking on proper quality control and volunteering in several national wide cannabis groups.  During our conversation we discuss: How growers can incorporate microbial testing into their processes Sources of microbial contamination and tips for prevention How differences in microbial regulations influence growers in certain states Remediation technologies and more  Thanks to This Episode's Sponsor: RS BioTherapeutics  RS BioTherapeutics' first investigational compound (RSBT-001) is a nebulized, semi-synthetic, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. More information on RS BioTherapeutics can be found at www.rsbiotherapeutics.com. Additional Resources Anthony Repay on LinkedInMethod Testing Laboratories websiteCannabis Microbial Testing Regulations by State [Interactive Tool]Request an Invitation to CannMed 23Review the Podcast!CannMed ArchiveCannMed Community Board [Facebook Group]Healthcare Provider Medical Cannabis Research Study

2.14 Acute Respiratory Distress Syndrome (ARDS) Pulmonary system review for the USMLE Step 1 Exam Acute respiratory distress syndrome (ARDS) is an acute, diffuse, inflammatory form of lung injury that is life-threatening for patients. ARDS is a response from the lungs to severe injury, most commonly caused by sepsis, but can also be caused by pneumonia, trauma, drowning, toxin inhalation, and pancreatitis. The lung injury from sepsis causes systemic inflammation, damaging lung tissue and causing diffuse alveolar damage, reducing surfactant production and causing alveolar edema. Patients with ARDS will present with progressive cough, progressive dyspnea, and hypoxia, and usually deteriorate quickly, 12-24 hours after symptom onset. Diagnosis of ARDS is based on imaging findings of bilateral lung infiltrates seen as white-out on chest X-ray and ground glass opacities on CT, as well as a decreased Pao2/Fio2 ratio to less than 300. Patients with ARDS are placed on mechanical ventilation with low tidal volume and positive end expiratory pressure (PEEP) to keep the alveoli open at the end of the respiratory cycle. Treatment of ARDS involves addressing the underlying cause of the disease, such as sepsis or pneumonia.  

Clazakizumab is a monoclonal antibody against human interleukin-6 that may benefit patients hospitalized with severe or critical COVID-19 accompanied by hyperinflammation. Although not yet FDA approved, clinical trials of clazakizumab for treatment of COVID-19 are under way worldwide. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, is joined by Bonnie E. Lonze, MD, PhD, to discuss the article, A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation, published in the September 2022 issue of Critical Care Medicine. Dr. Lonze is a faculty transplant surgeon at NYU Langone in New York, New York, USA, focusing primarily on kidney transplants. As vice chair for research of the NYU Langone Transplant Institute, she leads the research group on clinical trials and regulatory oversight.

One show note:  The statement "Nutritional marasmus was the default code for unspecified severe nutritional marasmus SHOULD be ....  was the default code for unspecified severe malnutrition".   Most of you probably knew what i meant. :)  Support the show

Article discussed in this episode:Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis

Episode Notes:TTN vs RDSNeonatal Resources, the Podcast Listen to Michelle and Darla compare and contrast transient tachypnea of the newborn with respiratory distress syndrome. They talk about:Risk factorsWho is most likely to be impactedThe importance of developmental careClinical managementThere is quite a bit of surfactant discussion, and to be fair, surfactant is often a huge component of NICU management. Check out the Get Your Pens blog To Surf or Not to Surf (if you don't see a hyperlink, check back, it's still in process) for a deep dive into methods of surfactant administration, what makes artificial surfactants work, and how the types of surfactant differ.For visual folks and side by side comparison…Get Your Pens.References:Amitai Komem, D., Meyer, R., Yinon, Y., & Levin, G. (2021). Prediction of meconium aspiration syndrome by data available before delivery. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14034 Alhassen, Z., Vali, P., Guglani, L., Lakshminrusimha, S., & Ryan, R. M. (2021). Recent Advances in Pathophysiology and Management of Transient Tachypnea of Newborn. Journal of Perinatology, 41(1), 6–16. https://doi.org/10.1038/s41372-020-0757-3Bonk, M. P., & Reilly, J. P. (2019). Clear as Mud: Diagnostic Uncertainty in Acute Respiratory Distress Syndrome. Annals of the American Thoracic Society, 16(2), 197–199. https://doi.org/10.1513/AnnalsATS.201810-697EDGomella, T. L., Eyal, F. G., & Bany-Mohammed, F. (2020). Neonatology; Management, Procedures, on-call problems, diseases, and drugs. (8th Ed).  McGraw Hill Lange. Chapter 106Jnah, A. J., & Trembath, A. N. (2019). Fetal and neonatal physiology for the advanced practice nurse. Springer Publishing Company. Chapter 4Jobe, A. H. (2019). Why, when, and how to give surfactant. Pediatric Research, 86(1), 15–16. https://doi.org/10.1038/s41390-019-0372-1Ng, E. H., & Shah, V. (2021). Guidelines for surfactant replacement therapy in neonates. Paediatrics & child health, 26(1), 35–49. https://doi.org/10.1093/pch/pxaa116Razak, A. (2022). Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome. JAMA: Journal of the American Medical Association, 327(16), 1613. https://doi.org/10.1001/jama.2022.2923For definitions of the terms we used, check out the full episode page at TTN vs RDS

This week, Rob and Zach will be teaching you everything you need to know about Acute Respiratory Distress Syndrome (ARDS).We will be discussing the following topics within this episode on ARDS!Definition of ARDSCauses / PathophysiologyClinical FeaturesPhysical Exam FindingsDiagnosisTreatmentTo follow along with Notes & Illustrations for our podcasts please become a member on our website! https://www.ninjanerd.org/podcast/pneumothoraxFollow us on:YouTube: https://www.youtube.com/ninjanerdscienceInstagram: https://www.instagram.com/ninjanerdlecturesFacebook: https://www.facebook.com/NinjaNerdLecturesTwitter: https://twitter.com/ninjanerdsciDiscord: https://discord.com/invite/3srTG4dngWTikTok: https://www.tiktok.com/@ninjanerdlecturesSupport the show

Acute respiratory distress syndrome (ARDS) has a stubbornly high mortality rate with current estimates at about 40%. Critical care veteran Kathleen Vollman, MSN, RN, CCNS lays the foundation of ARDS starting with pathophysiology followed by the “8 Ps” of evidence-based supportive care and summary of long-term prognosis.Check out Nicole Kupchik's exam reviews and practice questions at nicolekupchikconsulting.com. Use the promo code UPMYGAME20 to get 20% off all products.Use the promo code UMNG10 to get 10% off your order from Stoggles.Check out Kathleen Vollman's consulting business Advancing Nursing.Up My Nursing Game is partnering with VCU Health Continuing Education to offer FREE continuing education credits for registered nurses. Click here to obtain nursing credit (1.00).See the show notes at upmynursinggame.com.

In this “Breathe Easy Critical Perspective” podcast, Dr. Dominique Pepper interviews Drs. Jose Dianti and Ewan Goligher. They discuss their recent 2022 publication in the Blue Journal about the association of PEEP and Lung Recruitment Selection Strategies with Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-Analysis.

Episode #025    In this episode, we will talk about Acute Respiratory Distress Syndrome including:EtiologiesPathophysiologyPresenting Signs and SymtpomsTreatment ModalitiesBE SURE TO CHECK OUT MY CCRN REVIEW ONLINE COURSE for a presale price of $249.  Only a few days left for this special pricing!  Lifetime 24/7 access and one 30 hour continuing education certificate!!Come visit my website:  https://www.kayhoppepresents.comeMail:  kay@kayhoppepresents.comBlessings!Kay

This episode Brian, Awais, and Adnan welcome their co-resident Mo to the podcast to discuss the basics of ARDS and mechanical ventilation in these patients. As always, there are a lot of laughs and quite a bit of banter. We mention several trials during our discussion that are linked below (show notes).ARDSNet/ARMA trialhttps://www.nejm.org/doi/full/10.1056/NEJM200005043421801ARDSNet/ALVEOLI trialhttps://www.nejm.org/doi/full/10.1056/NEJMoa032193EXPRESS trialhttps://jamanetwork.com/journals/jama/fullarticle/181426LOVS trialhttps://jamanetwork.com/journals/jama/fullarticle/181425EPVENT trialhttps://jamanetwork.com/journals/jama/fullarticle/2725206PROSEVA trialhttps://www.nejm.org/doi/full/10.1056/nejmoa1214103Steroid use in ARDS - After review of the literature, use of steroids seems to be controversial and situation dependent. Apologies for the confusion.https://jintensivecare.biomedcentral.com/articles/10.1186/s40560-018-0321-9#Sec3

We are required to praise Hashem for every breath that we take. Of course, we often don't pay much attention to this critical task, as it is something that just happens for us without much thought. So take a deep breath and allow the appreciation to sink in. In this episode, we will hear the breathtaking story from a living miracle who was on Ecmo for close to 2 months, was placed into an induced coma, and survived despite being on the brink of death several times. A big thank you to Ben Taplin for sharing his story and experiences with us. To learn more about Kids of Courage, check out their website at kidsoc.org. Send us a screenshot of you writing us a review on Apple podcasts or posting the flyer and link to this episode on your WhatsApp status after 22 hours and get entered into a raffle to win a limited edition “Rolling with the Punches” zip-up sweatshirt. The winner will be announced in episode 3 of season 2. If you would like to appear on the show to represent a particular challenge, or if you have questions or comments or would like to be added to receive WhatsApp updates, email us at rollingwiththepunchespodcast@gmail.com. To partner with us or sponsor an episode email us at rollingwiththepunchespodcast@gmail.com. This show is available wherever you get your podcasts. Follow us on Facebook, Instagram, and Twitter to submit your questions for upcoming episodes. https://www.facebook.com/Rolling-with-the-Punches-101669291863891 http://instagram.com/rollingwiththepunchespodcast http://twitter.com/PunchesPodcast All information exchanged on this show is intended for educational and support purposes only. This information should not be considered treatment or medical advice. You must always follow your medical professional's advice and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition or mental disorder.

Acute Respiratory Distress Syndrome discussed by Dr JD Coakley Consultant Intensivist and Anaesthetist St James's Hospital. Please like or subscribe on whatever platform you listen to your podcasts on! Spread the word! Enjoy

In this episode, we review the high-yield topic of Acute Respiratory Distress Syndrome from the Pulmonary section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial

In this episode, we review the high-yield topic of Acute Respiratory Distress Syndrome (ARDS) from the Respiratory section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://anchor.fm/medbulletsstep1/message

Two previously published trials (ARDS et Curarisation Systematique and Reevaluation of Systemic Early Neuromuscular Blockade) presented equivocal evidence on the effect of neuromuscular blocking agent infusions in patients with acute respiratory distress syndrome.

What happens when your patient has been given a cric or intubated but continues to decline… SpO2 continues to slowly drop despite taking control of the airway. You have placed your patient on a ventilator and slowly adjusted the PEEP up to 20cmH20… which quickly leads to hypotension. Do you go lower? Higher? Change volume or rate? You are out of bottled O2 and your oxygen concentrator does not seem to have much effect. The SpO2 continues dropping. Telemedicine is not available. You try positioning the patient by sitting them up. You try a couple other recruitment maneuvers you heard about. Nothing is working. What would Doug do? Prone the patient??? Your patient may be suffering from ARDS, Acute Respiratory Distress Syndrome caused by a number of etiologies such as pneumonia or other lung injury. Carefully turning your patinet on their stomach may improve oxygenation by recruiting alveoli formerly compressed and “drowned” as demonstrated in the picture below. Positioning your patient on their stomach in the prone position must be practiced with anyone who will be helping you. Put someone else in a similar position and have the team with which you plan to help move the real patient do a couple rehearsals. You don't want to flip them over only to lose your IVs, IOs and yank the airway out. Check out this Brazilian article which includes a proning checklist and some informative pictures and tips. You also don't get an automatic win by flipping them on their belly and calling it a day. You will have to be even more vigilant about any potential complications with a dedicated airway person as is is a little harder to recognize a patient in distress if you are not used to it. You will also have to do more nursing care on the delicate skin of the face and other surfaces not normally on the down side: Shoulders, hips, knees tops of the feet. Put yourself in this position for a few minutes on a litter and you can quickly tell where the major pressure points will be. All of these complications increased along with the benefits of the study. While no prolonged field care patient should be on a bare litter, there is even more reason to move them to a mattress or other more comfortable padded surface. For more content, visit www.prolongedfieldcare.org

The role of #oxygen at times of #pandemic have a vital position, it's a major source of an element which is needed for #treating patients. Coronavirus second wave has impacted lives as many people succumbed to death or in dire need of oxygen as this new variant virus crippled the human body leading to #deaths in many cases. The ongoing surge in new #cases every day shows a direct impact on covid-19 management and this therapy where shortness of breath progresses to a more acute condition in patients who are affected by #virus. This can progress to a more #severe and systemic disease characterized by Acute Respiratory Distress Syndrome. Low levels of oxygen triggered by Covid-19 are #inflammatory markers. Severe cases are defined in three categories: severe #pneumonia, #acuterespiratory distress syndrome, and #sepsis. The clinical management protocol recommends oxygen therapy at 5 liters/min. When #respiratory distress and/or hypoxemia of the patient cannot be alleviated after receiving standard oxygen therapy. So, the above video helps in understanding what's happening deep inside. This educational content delivered by Mr. ChinnaRao, Deputy Commissioner, Health, AP going to provide you first-hand information exclusively in the #Telugu language and how we can overcome the oxygen crisis in this epidemic times. #TeluguPodcast #Chinnamaata --- Send in a voice message: https://podcasters.spotify.com/pod/show/chinna61/message

Discussion of ARDS diagnosis, management, and clinical trials -Pathophysiology of ARDS -Management guidelines including clinical trials that helped make those guidelines -COVID19 specific ARDS management -Will discuss briefly my intern podcast series

Acute Respiratory Distress Syndrome (ARDS)   from a chapter titled Critical Care by Shyoko Honiden, MD & Mark Siegel, MD Yale University School of Medicine from Baliga's Textbook of Internal Medicine with 1480 MCQs www.MasterMedFacts.com

In this episode, we discuss the approach to a sick patient with Acute Respiratory Distress Syndrome. We talk about diagnosis, classification of severity, common triggers and strategies for treatment. Also, tune in to our medicine minute to learn about the evidence behind ECMO in patients with ARDS!